What clinical features during a heart failure hospitalization make you defer SGLT-2 inhibitor initiation to outpatient follow-up rather than starting in-hospital?

I have witnessed clinical practice evolve considerably over the past few years on this topic, and there is now increasing emphasis and consensus around initiating SGLT-2 inhibitors during a heart failure hospitalization rather than waiting until after discharge. Evidence suggests that benefits begin...